CPIG
ABMD

Chicago Partners Investment Group’s Abiomed Inc ABMD Stock Holding History

Chicago Partners Investment Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-564
Closed -$211K – 665
2022
Q3 		$211K Buy
+564
New +$152K 0.02% 523
2021
Q4 		– Sell
-571
Closed -$204K – 626
2021
Q3 		$204K Buy
+571
New +$193K 0.01% 547

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Chicago Partners Investment Group's ABMD Position: Q4 2022 in Review

Chicago Partners Investment Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 564 shares — an estimated $211K sold.

Chicago Partners Investment Group first reported a position in ABMD in Q3 2021 and held it in 2 quarters. The position peaked at $211K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Chicago Partners Investment Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 564 Abiomed Inc shares in Q4 2022, an estimated $211K.
  • Chicago Partners Investment Group first reported a position in Abiomed Inc in Q3 2021 and held it in 2 quarters.
  • Chicago Partners Investment Group's Abiomed Inc position peaked at $211K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Chicago Partners Investment Group's 13F filing for Q4 2022, filed 9 Feb 2023.